For health care professionals

Provider education

Fred Hutchinson Cancer Center provides symposiums, webinars and other educational programs about specific disease programs focusing on advancements to diagnostic techniques and treatment modalities. Our programs feature physician speakers from Fred Hutch, UW Medicine and Seattle Children’s. 

Our mission

We strive to support Fred Hutch’s mission of advancing the standard of oncology care throughout the region by providing high quality medical education to healthcare providers. Our oncology-specific education services focus on current and emerging standards of care and treatment options along the cancer care continuum with the goal of improving patient outcomes.

Practical clinical training

In addition to symposiums and webinars, Fred Hutch offers other clinical education including multi-day training courses and shadowing programs.

Upcoming events

Fred Hutch offers educational symposiums throughout the year, with focuses on research advancements to diagnostic techniques and treatment modalities.

13th Annual Comprehensive Hematology and Oncology Review Course
13th Annual Comprehensive Hematology and Oncology Review Course

On-demand course available December 1, 2022 – November 30, 2023

This educational program will cover data supporting guidelines, recommendations and recent advances regarding therapeutic options for patients with solid tumors and malignant and nonmalignant hematologic disorders. 

9th Annual Pacific Northwest Head and Neck Cancer Symposium: Thyroid Disorders - Guidelines, Guidance, and Common Sense
9th Annual Pacific Northwest Head and Neck Cancer Symposium: Thyroid Disorders - Guidelines, Guidance, and Common Sense

May 5, 2023

Presented by Fred Hutch and Swedish, this single-day course will provide leading-edge information for clinicians who care for patients with benign and malignant thyroid disorders. A multidisciplinary panel of experts will discuss the most recent clinical innovations and new management protocols for treating thyroid nodules, thyroiditis, and thyroid cancer.

Breast Cancer Symposium: Improving Therapeutics Through Multidisciplinary Collaboration
Breast Cancer Symposium: Improving Therapeutics Through Multidisciplinary Collaboration

May 19, 2023

Join nationally-renowned experts from Fred Hutchinson Cancer Center for this one-day symposium in Seattle, WA. Researchers and health care professionals caring for patients with breast cancer will learn to assess clinical practice and research findings to advance care of breast malignancies, reduce mortality rates, and increase survival rates.

Immune-Related Adverse Events – A Series of Panels Exploring the Side Effects of Immunotherapy

Immune-Related Adverse Events (irAEs), provider-focused discussions on immunotherapy-related treatment, research updates and clinical challenges. 

The 90-minute sessions are approximately half didactic information presented by experts in the field and half panel case discussion and questions. Series co-chaired by Shailender Bhatia, MD and Petros Grivas, MD, PhD

Accreditation: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Washington School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 1.0 credit.)

irAEs Panel Series Presentations

Panel 1 Topic: Immune-Related GI Toxicity: updates and clinical dilemma
Recorded on April 24, 2021. Guest speaker is Yinghong (Mimi) Wang, MD, PhD, Associate Professor at MD Anderson Cancer Center.
Panel 2 Topic: Immune-Mediated Pneumonitis
Recorded on June 26, 2021. Guest speaker is Jarushka Naidoo, M.B.B.Ch, Assistant Professor of Oncology at Johns Hopkins.
Panel 3 Topic: Rheumatologic irAEs
Recorded on October 9, 2021. Guest speaker is Maria Suarez-Almazor, MD, PhD, Barnts Family Distinguished Professor at MD Anderson Cancer Center.
Panel 4 Topic: Renal irAEs: Nephrotoxicity of Immune Checkpoint Inhibitors
Recorded on January 29, 2022. Guest speaker is Shruti Gupta, MD, MPH, Director of Onco-Nephrology, Division of Renal Medicine, Brigham and Women’s Hospital/Dana-Farber Cancer Institute.
Panel 5 Topic: ICI-induced Myocarditis
Recorded April 8, 2022. Guest Speaker is Tomas Neilan, MD, MPH Director, Cardio-Oncology Program and Co-Director, Cardiac MR PET CT Program at Massachusetts General Hospital.
Panel 6 Topic: Immune-Related Adverse Events (IrAEs) – a Series of Panels Exploring the Side Effects of Immunotherapy
Recorded on September 23, 2022. Guest speaker is Mario E. Lacouture, MD, Professor and Director, Oncodermatology Program, Dermatology Service, Department of Medicine at Memorial Sloan-Kettering Cancer Center.